2013•Journal of Clinical NeuroscienceRequires access

Intracisternal administration of SB203580, a p38 mitogen-activated protein kinase inhibitor, attenuates cerebral vasospasm via inhibition of tumor-necrosis factor-α

Yunxi Pan, Kefei Chen, Yixing Lin, Wei Wu, Xiaoming Zhou, Xiangsheng Zhang, Xin Zhang, Ji‐Xin Shi

Open publisher page 24 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 24 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Cerebral vasospasm, Subarachnoid hemorrhage, Vasospasm, Basilar artery, p38 mitogen-activated protein kinases, Tumor necrosis factor alpha, Anesthesia

Back to paper search Browse research topics Original source

Intracisternal administration of SB203580, a p38 mitogen-activated protein kinase inhibitor, attenuates cerebral vasospasm via inhibition of tumor-necrosis factor-α — Research Paper | ScholarLens